Éric Charpentier
Centre National de la Recherche Scientifique(FR)Inserm(FR)Centre Hospitalier Universitaire de Nantes(FR)Institut du Thorax(FR)Nantes Université(FR)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Monoclonal and Polyclonal Antibodies Research, Cancer Treatment and Pharmacology, PARP inhibition in cancer therapy, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death(2013)542 cited
- → Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer(2014)301 cited
- → A randomized phase III study of iniparib (BSI-201) in combination with gemcitabine/carboplatin (G/C) in metastatic triple-negative breast cancer (TNBC).(2011)244 cited
- → De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability(2017)197 cited
- → Induction of Human Trophoblast Stem Cells from Somatic Cells and Pluripotent Stem Cells(2020)178 cited
- → A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma(2017)